MarginsXMarginsX
Home › Markets › Health Care › CMPS

COMPASS Pathways Plc American Depository Shares (CMPS)

CMPS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$8.27
-8.21% on the day
Market cap
$1.2B
Small cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerCMPS on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited Kingdom
IPO year2020
SEC CIK0001816590
SEC industry codePharmaceutical Preparations
Incorporated inUnited Kingdom

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
30.1 months
$444.0M cash at September 30, 2026
Share count, 1 year
+47.6%
2025-10-30 to 2026-10-28 · +128.9% over 3 years
Going-concern doubt
No
10-Q filed November 3, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-03
Cash and burn$444.0M cash; operating cash flow -$44.2M a quarter.Report 2026-09-30
Shares outstanding141,710,353 (2026-10-28); 96,017,044 a year earlier; 61,896,535 three years earlier.Cover page 2026-10-28
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-02-19
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Boston, Massachusetts, United States; changed auditors 1 time in 24 months8-K 4.01 2025-04-16
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$9.8M-$50.8M$444.0M$51.0MNeeds four quarters10-Q 2026-11-03
Q2 2026
2026-06-30
Not filed-$253.8M-$40.3M$433.3M$50.7MNeeds four quarters10-Q 2026-11-03
Q1 2026
2026-03-31
Not filed$91.2M-$47.9M$466.0M$50.5MNeeds four quarters10-Q 2026-11-03
Q4 2025
2025-12-31
Not filed-$93.9M-$37.8M$149.6M$31.6MNeeds four quarters10-K 2026-03-24
Q3 2025
2025-09-30
Not filed-$137.7M-$35.1M$185.9M$31.3MNeeds four quarters10-Q 2026-11-03
Q2 2025
2025-06-30
Not filed-$38.4M-$38.7M$221.9M$30.9MNeeds four quarters10-Q 2026-11-03
Q1 2025
2025-03-31
Not filed-$17.9M-$45.7M$260.1M$30.5MNeeds four quarters10-Q 2026-11-03
Q4 2024
2024-12-31
Not filed-$43.3M-$41.8M$165.1M$30.2MNeeds four quarters10-K 2026-03-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-08-05
Latest annual report10-K2026-03-24
Latest quarterly / interim10-Q2026-11-03
Latest current report8-K2026-11-03
Latest proxyDEF 14A2026-04-15

Source: SEC EDGAR submissions feed, 344 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.6%
1 month-19.1%
3 months-32.2%
Year to date+30.6%
1 year+70.3%
From 52-week high-40.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
KARDKardigan Inc.$12.85-7.02%$1.2B
OPKOPKO Health Inc.$1.62-3.57%$1.2B
OMEROmeros Corporation$16.68-4.63%$1.2B
SLNSilence Therapeutics Plc American Depository Share$19.80-0.15%$1.2B
AAPGAscentage Pharma Group International American Depository Shares$13.29-9.10%$1.2B
AMPHAmphastar Pharmaceuticals Inc.$29.17-0.68%$1.2B
NKTRNektar Therapeutics$36.44-2.23%$1.2B
HROWHarrow Inc.$29.09-3.42%$1.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier